CBWTD Stock Chart & Stats
$2.28
--
At close: 4:00 PM EDT
$2.28
--
Day’s Range― - ―
52-Week Range$1.06 - $2.39
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.04M
Market Cap
$234.74M
Enterprise Value$301.99
Total Cash (Recent Filing)$38.95M
Total Debt (Recent Filing)$53.67M
Price to Earnings (P/E)9.4
Beta0.44
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding103,235,435
10 Day Avg. Volume1,190,854
30 Day Avg. Volume1,035,144
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.25
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$2.90Price Target Upside27.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.1
Revenue Forecast (FY)$116.67M
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA GrowthDouble-digit revenue growth alongside faster EBITDA expansion indicates improving scale and operating leverage. Sustained 31% EBITDA margins for five consecutive quarters support the durability of the company’s branded-product model.
Structural Margin ImprovementMargin gains tied to cultivation yields, manufacturing processes, procurement savings and product mix are operational improvements rather than temporary market effects. These changes can support profitability as volumes expand across the Canadian market.
Strong Cash Generation And Balance SheetPositive operating and free cash flow, combined with materially lower leverage, gives Auxly greater flexibility to fund investment internally and manage obligations. Strong cash conversion also reduces dependence on external financing for growth.
Bears Say
TTM Margin CompressionDespite remaining profitable, lower trailing margins and slower revenue growth raise questions about the consistency of recent operating gains. Persistent pricing pressure, higher costs or unfavorable product mix could limit earnings growth over the next several quarters.
Capital Program Execution And Funding RiskThe expansion could improve future capacity and unit economics, but it requires infrastructure upgrades and sustained cash generation over multiple years. Delays, cost overruns or weaker operations could constrain liquidity and postpone the expected benefits.
Limited International Growth OptionalityA Canada-focused strategy reduces regulatory complexity but also limits geographic diversification and the addressable growth runway. Continued caution toward international markets leaves Auxly more exposed to Canadian competition, provincial purchasing and domestic pricing pressure.
CBWTD FAQ
What was Auxly Cannabis Group’s price range in the past 12 months?
Auxly Cannabis Group lowest stock price was $1.06 and its highest was $2.39 in the past 12 months.
What is Auxly Cannabis Group’s market cap?
Auxly Cannabis Group’s market cap is $234.74M.
When is Auxly Cannabis Group’s upcoming earnings report date?
Auxly Cannabis Group’s upcoming earnings report date is Nov 16, 2026 which is in 80 days.
How were Auxly Cannabis Group’s earnings last quarter?
Auxly Cannabis Group released its earnings results on Aug 13, 2026. The company reported $0.051 earnings per share for the quarter, the consensus estimate of $0.051 by $0.
Is Auxly Cannabis Group overvalued?
According to Wall Street analysts Auxly Cannabis Group’s price is currently Undervalued.
Does Auxly Cannabis Group pay dividends?
Auxly Cannabis Group does not currently pay dividends.
What is Auxly Cannabis Group’s EPS estimate?
Auxly Cannabis Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Auxly Cannabis Group have?
Auxly Cannabis Group has 103,235,435 shares outstanding.
What happened to Auxly Cannabis Group’s price movement after its last earnings report?
Auxly Cannabis Group reported an EPS of $0.051 in its last earnings report, expectations of $0.051. Following the earnings report the stock price went down -6.913%.
Which hedge fund is a major shareholder of Auxly Cannabis Group?
Currently, no hedge funds are holding shares in CBWTD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auxly Cannabis Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.90 (27.18% Upside)
$2.90 (27.18% Upside)
Insider Transactions
Bought Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
182.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.77%
Trailing 12-Months
Company Description
Auxly Cannabis Group
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis formats under its distinct brands—KOLAB PROJECT, Dosecann, BACK FORTY, and Foray—including vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. Originally incorporated in 1987, the company was known as Cannabis Wheaton Income Corp. before officially changing its name to Auxly Cannabis Group Inc. in June 2018. It is headquartered in Toronto, Canada.
CBWTD Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents multiple strong operational and financial positives: double-digit revenue growth (+18% YoY), improving gross margins (55%, +3pp), record adjusted EBITDA (+24% YoY) and very strong cash conversion (94%). Product innovation and distribution momentum (Liquid Imagination, Back Forty, Galactic Jack) and an articulated $30M 3-year capital plan to raise yields are constructive. Offsetting items are accounting-driven net income volatility from noncash fair-value adjustments, higher SG&A to support growth, modest net debt (~$6M), and execution/funding risk related to the multi-year capacity expansion and cautious stance on international expansion. Overall, the highlights materially outweigh the lowlights.View all CBWTD earnings summariesCBWTD Stock 12 Month Forecast
Average Price Target
$2.90
▲(27.18% Upside)